BRAIN TUMOR LIBRARY
Brain tumors | Treatment
48




Home > Brain tumor library > Brain tumors > Treatment


Overviews



IMMUNOTHERAPY



Sampson JH, Maus MV, June CH.
Immunotherapy for Brain Tumors.
J Clin Oncol. 2017 Jun 22:JCO2017728089. doi: 10.1200/JCO.2017.72.8089. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



NANOMEDICINE



Reynolds JL, Mahato RI.
Nanomedicines for the Treatment of CNS Diseases.
J Neuroimmune Pharmacol. 2017 Mar;12(1):1-5. doi: 10.1007/s11481-017-9725-x. Epub 2017 Feb 1.
Source | Abstract | Full text | Similar articles





R.A.N.O. RESPONSE CRITERIA



Wen PY, Chang SM, Van den Bent MJ, Vogelbaum MA, Macdonald DR, Lee EQ.
Response Assessment in Neuro-Oncology Clinical Trials.
J Clin Oncol. 2017 Jun 22:JCO2017727511. doi: 10.1200/JCO.2017.72.7511. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



CHILDHOOD BRAIN AND SPINAL CORD TUMORS



PDQ Pediatric Treatment Editorial Board.
Childhood Brain and Spinal Cord Tumors Treatment Overview (PDQ®): Patient Version.
PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-2017 Feb 8.
Source | Abstract | Full text | Similar articles




PDQ Pediatric Treatment Editorial Board.
Childhood Brain and Spinal Cord Tumors Treatment Overview (PDQ®): Patient Version.
PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-.2016 Aug 26.
Source | Abstract | Full text | Similar articles





RADIOTHERAPY



Combs SE.
Does Proton Therapy Have a Future in CNS Tumors?
Curr Treat Options Neurol. 2017 Mar;19(3):12. doi: 10.1007/s11940-017-0447-4.
Source | Abstract | Full text | Similar articles





STEROIDS


**

Ly KI, Wen PY.
Clinical Relevance of Steroid Use in Neuro-Oncology.
Curr Neurol Neurosci Rep. 2017 Jan;17(1):5. doi: 10.1007/s11910-017-0713-6. Online 2017 Jan 30.
Source | Abstract | Full text | Similar articles





Clinical investigations


Newly diagnosed tumors



RIDAFOROLIMUS



Pearson AD, Federico SM, Aerts I, Hargrave DR, DuBois SG, Iannone R, Geschwindt RD, Wang R, Haluska FG, Trippett TM, Geoerger B.
A phase 1 study of oral ridaforolimus in pediatric patients with advanced solid tumors.
Oncotarget. 2016 Oct 4. doi: 10.18632/oncotarget.12450. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



SURGERY



Roth J, Constantini S.
5ALA in pediatric brain tumors is not routinely beneficial.
Childs Nerv Syst. 2017 Mar 14. doi: 10.1007/s00381-017-3371-8. [Epub ahead of print]

Source | Abstract | Full text | Similar articles





Recurrent tumors



IMETELSTAT



Salloum R, Hummel TR, Kumar SS, Dorris K, Li S, Lin T, Daryani VM, Stewart CF, Miles L, Poussaint TY, Stevenson C, Goldman S, Dhall G, Packer R, Fisher P, Pollack IF, Fouladi M, Boyett J, Drissi R.
A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study.
J Neurooncol. 2016 Jun 27. [Epub ahead of print]
Source | Abstract | Full text | Meeting abstract (2015)





PEDIATRIC TUMORS



Becher OJ, Gilheeney SW, Khakoo Y, Lyden DC, Haque S, De Braganca KC, Kolesar JM, Huse JT, Modak S, Wexler LH, Kramer K, Spasojevic I, Dunkel IJ.
A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors.
Pediatr Blood Cancer. 2016 Dec 30. doi: 10.1002/pbc.26409. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





PEMBROLIZUMAB



Blumenthal DT, Yalon M, Vainer GW, Lossos A, Yust S, Tzach L, Cagnano E, Limon D, Bokstein F.
Pembrolizumab: first experience with recurrent primary central nervous system (CNS) tumors.
J Neurooncol. 2016 Jul 4. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





RE-IRRADIATION



Nieder C, Andratschke NH, Grosu AL.
Re-irradiation for Recurrent Primary Brain Tumors.
Anticancer Res. 2016 Oct;36(10):4985-4995.
Source | Abstract | Full text | Similar articles





TEMOZOLOMIDE



Egan G, Cervone KA, Philips PC, Belasco JB, Finlay JL, Gardner SL.
Phase I study of temozolomide in combination with thiotepa and carboplatin with autologous hematopoietic cell rescue in patients with malignant brain tumors with minimal residual disease.
Bone Marrow Transplant. 2016 Apr;51(4):542-5. doi: 10.1038/bmt.2015.313. Epub 2016 Jan 4.
Source | Abstract | Full text | Similar articles